Are long-chain polyunsaturated fatty acids essential nutrients in infancy?

Area of Science:

• Nutritional Neuroscience
• Infant Development
• Ophthalmology

Background:

• Neural maturation disparities exist between breastfed and formula-fed infants.
• Docosahexaenoic acid (DHA) is a key omega-3 fatty acid vital for brain and visual development.
• The impact of DHA supplementation on neural maturation in term infants requires further investigation.

Purpose of the Study:

• To determine if DHA supplementation in infant formula can correct neural maturation differences compared to breastfed infants.
• To assess the effect of DHA on visual evoked potential (VEP) acuity and erythrocyte fatty acid levels.
• To investigate the necessity of a continuous DHA supply for optimal infant neural development.

Main Methods:

• Randomized controlled trial comparing supplemented formula, placebo formula, and breastfed infants.
• Assessment of infant erythrocyte fatty acids and anthropometry at multiple time points.
• Measurement of visual evoked potential (VEP) acuity at 16 and 30 weeks of age.

Main Results:

• Infants fed DHA-supplemented formula showed VEP acuities comparable to breastfed infants, significantly better than placebo-fed infants.
• Erythrocyte DHA levels were maintained in breastfed and supplemented groups but decreased in the placebo group.
• Higher erythrocyte DHA levels correlated with better VEP acuity; continuous DHA supply appeared necessary for optimal VEP development.

Conclusions:

• Docosahexaenoic acid (DHA) is essential for optimal neural maturation in term infants, as indicated by VEP acuity.
• Supplementing infant formula with DHA can bridge the neural maturation gap observed in formula-fed infants.
• Further research is needed to determine the long-term benefits of DHA supplementation in formula-fed infants.